T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 | +$1.82B | |
| 2 | +$1.38B | |
| 3 | +$1.16B | |
| 4 |
Netflix
NFLX
|
+$1.14B |
| 5 |
Ingersoll Rand
IR
|
+$1.03B |
Top Sells
| 1 | +$4.73B | |
| 2 | +$3.54B | |
| 3 | +$1.75B | |
| 4 |
Amphenol
APH
|
+$1.65B |
| 5 |
KLA
KLAC
|
+$1.5B |
Sector Composition
| 1 | Technology | 33.6% |
| 2 | Financials | 11.17% |
| 3 | Healthcare | 11.1% |
| 4 | Communication Services | 10.25% |
| 5 | Consumer Discretionary | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Deckers Outdoor
DECK
$15.9B
| $20.5M | ﹤0.01% |
204,360
-413,564
|
|
||
1027
Ero Copper
ERO
$2.89B
| $20.3M | ﹤0.01% |
762,698
-3,833,352
|
|
||
1028
iShares Russell 1000 Growth ETF
IWF
$126B
| $20.3M | ﹤0.01% |
190,636
-1,084,724
|
|
||
1029
Alpha Metallurgical Resources
AMR
$2.4B
| $20.3M | ﹤0.01% |
98,956
-12,570
|
|
||
1030
Applied Digital
APLD
$11.9B
| $20.2M | ﹤0.01% |
852,435
+391,309
|
|
||
1031
Gaming and Leisure Properties
GLPI
$13.6B
| $20.2M | ﹤0.01% |
454,580
+105,688
|
|
||
1032
Core & Main
CNM
$9.69B
| $20.1M | ﹤0.01% |
406,703
+78,110
|
|
||
1033
Invitation Homes
INVH
$17.5B
| $20M | ﹤0.01% |
806,290
-9,457
|
|
||
1034
ADMA Biologics
ADMA
$1.93B
| $20M | ﹤0.01% |
2,216,285
+55,726
|
|
||
1035
Neurocrine Biosciences
NBIX
$16.4B
| $19.9M | ﹤0.01% |
151,256
-1,720,984
|
|
||
1036
V2X
VVX
$2.82B
| $19.9M | ﹤0.01% |
290,562
+269,277
|
|
||
1037
EnerSys
ENS
$8.14B
| $19.9M | ﹤0.01% |
114,545
-278,236
|
|
||
1038
EverQuote
EVER
$702M
| $19.8M | ﹤0.01% |
1,283,327
+975,201
|
|
||
|
RERE
1039
ATRenew
RERE
$913M
| $19.6M | ﹤0.01% |
4,183,954
+326,270
|
|
||
1040
MasTec
MTZ
$28.3B
| $19.6M | ﹤0.01% |
60,807
+6,024
|
|
||
1041
Bausch + Lomb
BLCO
$5.45B
| $19.5M | ﹤0.01% |
1,224,603
-35,703
|
|
||
|
CRWV
1042
CoreWeave Inc
CRWV
$52.2B
| $19.4M | ﹤0.01% |
249,862
+172,678
|
|
||
1043
DoubleVerify
DV
$1.57B
| $19.3M | ﹤0.01% |
2,032,035
+19,255
|
|
||
1044
Interparfums
IPAR
$3.21B
| $19.3M | ﹤0.01% |
212,381
+3,316
|
|
||
1045
Tarsus Pharmaceuticals
TARS
$2.69B
| $19.3M | ﹤0.01% |
274,804
-243,976
|
|
||
1046
Peabody Energy
BTU
$3.21B
| $19.2M | ﹤0.01% |
583,681
+468,741
|
|
||
1047
Relay Therapeutics
RLAY
$3.1B
| $19.2M | ﹤0.01% |
1,924,938
+279,535
|
|
||
1048
Catalyst Pharmaceutical
CPRX
$3.84B
| $19.2M | ﹤0.01% |
773,446
+24,665
|
|
||
1049
Teva Pharmaceuticals
TEVA
$40.2B
| $19.1M | ﹤0.01% |
634,136
-925,466
|
|
||
1050
Nutanix
NTNX
$13.3B
| $19M | ﹤0.01% |
500,150
-236,126
|
|